Serum RANTES, transforming growth factor-beta1, and interleukin-6 levels correlate with cardiac muscle fibrosis in patients with aortic valve stenosis

• Autorzy: Podolec J. , Baran J. , Siedlinski M. , Urbanczyk M. , Krupinski M. , Bartus K. , Niewiara L. , Podolec M. , Guzik T. , Tomkiewicz-Pajak L. , Komar M. , Kablak-Ziembicka A.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

aortic stenosis; aortic valve disease; chemokine; inflammation; interleukin 6; transforming growth factor-beta; fibrosis; cardiac muscle; patient

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2018
• Tom: 69
• Numer: 4
• Opis fizyczny: p.615-623,fig.,ref.

Twórcy

autor

Podolec J.

• Department of Interventional Cardiology, Jagiellonian University College of Medicine and the John Paul II Hospital, 80 Pradnicka Street, 31-202 Krakow, Poland

autor

Baran J.

• Department of Interventional Cardiology, Jagiellonian University College of Medicine and the John Paul II Hospital, Krakow, Poland

autor

Siedlinski M.

• Department of Internal and Agricultural Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Urbanczyk M.

• Radiology Department, John Paul II Hospital, Krakow, Poland

autor

Krupinski M.

• Radiology Department, John Paul II Hospital, Krakow, Poland

autor

Bartus K.

• Department of Cardiovascular Surgery and Transplantology, Jagiellonian University, John Paul II Hospital, Krakow, Poland

autor

Niewiara L.

• Department of Interventional Cardiology, Jagiellonian University College of Medicine and the John Paul II Hospital, Krakow, Poland

autor

Podolec M.

• Department of Coronary Artery Disease, Jagiellonian University College of Medicine and the John Paul II Hospital, Krakow, Poland

autor

Guzik T.

• Department of Internal and Agricultural Medicine, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland
• British Heart Foundation Centre for Excellence, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U. K.

autor

Tomkiewicz-Pajak L.

• Department of Cardiac and Vascular Diseases, Jagiellonian University College of Medicine and the John Paul II Hospital, Krakow, Poland

autor

Komar M.

• Department of Cardiac and Vascular Diseases, Jagiellonian University College of Medicine and the John Paul II Hospital, Krakow, Poland

autor

Kablak-Ziembicka A.

• Department of Interventional Cardiology, Jagiellonian University College of Medicine and the John Paul II Hospital, Krakow, Poland

Identyfikatory

DOI

10.26402/jpp.2018.4.12